Tilray Brands, Inc. Debt Securities, Available-for-sale, Realized Gain (Loss)
Tilray Brands, Inc. (TLRY) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $0 for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2026-07-28
- Tilray Brands, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-05-31 was $0.00.
- Tilray Brands, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-02-28 was $0.00.
- Tilray Brands, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-11-30 was $0.00.
- Tilray Brands, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-08-31 was $0.00.
- Tilray Brands, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2026 was $0.00.
- Tilray Brands, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2025 was $0.00.
- Tilray Brands, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2024 was -$19.74M.
- Tilray Brands, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2023 was -$43.65M, a 126.67% decline from fiscal 2022.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-05-31 | $0.00 10-K · filed 2026-07-28 | |||
| 2025-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $0.00 derived: sum of 2 quarters · filed 2026-07-28 | $0.00 derived: sum of 3 quarters · filed 2026-07-28 | $0.00 10-K · filed 2026-07-28 |
| 2025-02-28 | $0.00 10-Q · filed 2025-04-08 | $0.00 derived: sum of 2 quarters · filed 2025-04-08 | $0.00 10-Q · filed 2025-04-08 | -$7.38M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $0.00 10-Q · filed 2025-01-10 | $0.00 10-Q · filed 2025-01-10 | -$7.38M derived: sum of 3 quarters · filed 2026-07-28 | -$13.70M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $0.00 10-Q · filed 2024-10-10 | -$7.38M derived: sum of 2 quarters · filed 2026-07-28 | -$13.70M derived: sum of 3 quarters · filed 2026-07-28 | -$17.59M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | -$7.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | -$13.70M derived: sum of 2 quarters · filed 2026-07-28 | -$17.59M derived: sum of 3 quarters · filed 2026-07-28 | -$19.74M 10-K · filed 2026-07-28 |
| 2024-02-29 | -$6.31M 10-Q · filed 2025-04-08 | -$10.21M derived: sum of 2 quarters · filed 2025-04-08 | -$12.35M 10-Q · filed 2025-04-08 | -$35.63M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | -$3.89M 10-Q · filed 2025-01-10 | -$6.04M 10-Q · filed 2025-01-10 | -$29.32M derived: sum of 3 quarters · filed 2025-07-29 | -$29.11M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | -$2.15M 10-Q · filed 2024-10-10 | -$25.42M derived: sum of 2 quarters · filed 2025-07-29 | -$25.22M derived: sum of 3 quarters · filed 2025-07-29 | -$37.91M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | -$23.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | -$23.07M derived: sum of 2 quarters · filed 2025-07-29 | -$35.77M derived: sum of 3 quarters · filed 2025-07-29 | -$43.65M 10-K · filed 2025-07-29 |
| 2023-02-28 | $207.00K 10-Q · filed 2024-04-09 | -$12.49M derived: sum of 2 quarters · filed 2024-04-09 | -$20.38M 10-Q · filed 2024-04-09 | -$8.56M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | -$12.70M 10-Q · filed 2024-01-09 | -$20.58M 10-Q · filed 2024-01-09 | -$8.76M derived: sum of 3 quarters · filed 2024-10-10 | $47.37M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | -$7.88M 10-Q · filed 2024-10-10 | $3.94M derived: sum of 2 quarters · filed 2024-10-10 | $60.06M derived: sum of 3 quarters · filed 2024-10-10 | $116.42M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $11.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $67.95M derived: sum of 2 quarters · filed 2024-07-30 | $124.30M derived: sum of 3 quarters · filed 2024-07-30 | $163.67M 10-K · filed 2024-07-30 |
| 2022-02-28 | $56.13M 10-Q · filed 2023-04-10 | $112.48M derived: sum of 2 quarters · filed 2023-04-10 | $151.85M 10-Q · filed 2023-04-10 | |
| 2021-11-30 | $56.35M 10-Q · filed 2023-01-09 | $95.72M 10-Q · filed 2023-01-09 | ||
| 2021-08-31 | $39.37M 10-Q · filed 2022-10-07 | |||
| 2021-05-31 | -$170.45M 10-K · filed 2023-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |